RxDoctor Payments Data

Susan Schneidermesser, DPM

Foot Surgery · Brooklyn, NYNPI 1548330764

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (57.6%), travel and lodging and other — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Treace Medical Concepts, Inc. at 47.2% of the total. 2025 is the largest year on record at $2,875, 9.1 times the $316 reported in 2019. Among foot surgery clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,048in general payments, 2019–2025

Across 77 payments — averaging $78.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Treace Medical Concepts, Inc.$3K
  • Stryker$1K
  • Organogenesis Inc.$1K
  • Smith+Nephew$311
  • Aroa Biosurgery Incorporated$202
  • Paragon 28, Inc.$159
  • plus $322 from 8 others

What the payments were for

  • Travel & lodging$1,56726%
  • Food & beverage$3,48158%
  • Other$1,00017%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,048 in reported general payments places this provider in the 90th percentile of 294 foot surgery providers in New York.

See all foot surgery providers in New York

Medicare billing

Part B allowed, 2024
$180,501
Medicare patients
492
Services billed
3,521

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Doxepin Hcl316$41,344
Fluocinonide479$39,984
Diclofenac Sodium ErDiclofenac Sodium234$18,446
Clotrimazole130$6,964
Naproxen Sodium29$2,524
Etodolac20$2,520
Fluconazole16$2,196
Ammonium Lactate61$1,397
Ciclopirox35$1,286
Ketoconazole12$319
Mupirocin31$177
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav13$105
Cephalexin16$96
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen13$89
Acetaminophen-CodeineAcetaminophen With Codeine11$66

Paid to pharmacies, not to this prescriber.

Other foot surgery in Brooklyn

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →